4D Molecular Therapeutics, Inc. (FDMT)
9.72
-0.19
(-1.92%)
USD |
NASDAQ |
Jun 01, 16:00
9.71
-0.01
(-0.10%)
After-Hours: 20:00
4D Molecular Therapeutics Profit Margin (Quarterly) : -2.26K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -34.46K% |
| Agenus, Inc. | -- |
| Amgen, Inc. | 21.02% |
| Anika Therapeutics, Inc. | -17.07% |
| BioCryst Pharmaceuticals, Inc. | -461.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -36.29% |
| Return on Assets | -32.27% |
| Return on Invested Capital | -34.55% |
| Gross Profit Margin (Quarterly) | 32.56% |
| Operating Margin (Quarterly) | -2.42K% |
| Return on Net Operating Assets | -459.0% |